Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
48.9M
-
Shares change
-
-2.91M
-
Total reported value, excl. options
-
$159M
-
Value change
-
-$18.7M
-
Put/Call ratio
-
0
-
Number of buys
-
88
-
Number of sells
-
-50
-
Price
-
$3.24
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q3 2022
163 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q3 2022.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.9M shares
of 127M outstanding shares and own 38.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10.5M shares), Soleus Capital Management, L.P. (6.49M shares), VANGUARD GROUP INC (4.48M shares), STATE STREET CORP (2.05M shares), Assenagon Asset Management S.A. (2.01M shares), MILLENNIUM MANAGEMENT LLC (1.5M shares), GEODE CAPITAL MANAGEMENT, LLC (1.31M shares), AQR CAPITAL MANAGEMENT LLC (1.29M shares), TWO SIGMA ADVISERS, LP (1.28M shares), and RENAISSANCE TECHNOLOGIES LLC (1.18M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.